NJ-based Johnson & Johnson says COVID-19 vaccine is safe, showing promising immune response
Johnson & Johnson says its COVID-19 vaccine is safe and showing a promising immune response.
News 12 Staff
•
Jan 14, 2021, 12:19 PM
•
Updated 1,198 days ago
Share:
More Stories
Hometown Heroes in New Jersey
9ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
207ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
218ds ago
Murphy administration: No plans to implement any COVID-19 restrictions
224ds ago0:39
Cape May hospital asking patients to wear mask amid COVID surge
225ds ago2:57
Lawmakers call for investigation, overhaul following DOJ report about NJ’s COVID response in veterans homes
227ds agoHometown Heroes in New Jersey
9ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
207ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
218ds agoMurphy administration: No plans to implement any COVID-19 restrictions
224ds ago0:39
Cape May hospital asking patients to wear mask amid COVID surge
225ds ago2:57
Lawmakers call for investigation, overhaul following DOJ report about NJ’s COVID response in veterans homes
227ds agoJohnson & Johnson says its COVID-19 vaccine is safe and
showing a promising immune response.
The company has reported few
side effects in early trials, things such as headache, muscle aches, and
soreness.
Data shows most volunteers
developed antibodies after 28 days.
Johnson & Johnson's
vaccine requires only one dose, while Pfizer's and Moderna's require two.
